封面
市場調查報告書
商品編碼
1098611

外用皮質類固醇的市場規模、份額、前景和機會(2022-2030 年):按配方、用途、分銷渠道和地區劃分

Topical Corticosteroids Market, by Formulation, by Application, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

進入者專注於推出仿製藥,預計將在預測期內為全球本地皮質類固醇(類固醇)市場的增長做出貢獻。在預測期內,公司收購和增加更好地治療濕疹的舉措等戰略也有望幫助市場增長。

本報告調查全球本地皮質類固醇(類固醇)市場,定義和概述市場,分析影響市場增長、法律和監管/贖回環境的各種影響因素,以及市場規模的變化/預測。,按類別細分/總結地區/主要國家、競爭環境、主要公司概況等。

目錄

第 1 章調查目標/先決條件

第二章市場概述

第三章市場動態/監管/趨勢分析

  • 市場動態
    • 促進因素
    • 抑制器
    • 市場機會
  • 影響分析
  • 波特分析
  • 行業趨勢
  • 主要亮點
  • 流行病學
  • 兌換場景
  • 監管場景
  • 產品發布/批准
  • 收購/結盟場景

第 4 章全球皮質類固醇(類固醇)市場:COVID-19 的影響

  • COVID-19:流行病學
  • COVID-19 對局部皮質類固醇供需的影響
  • COVID-19 對整個醫療保健行業的影響

第 5 章全球皮質類固醇(類固醇)市場:按配方

  • 奶油
  • 軟膏
  • 凝膠
  • 其他

第 6 章全球皮質類固醇(類固醇)市場:按應用

  • 痤瘡
  • 皮炎
  • 牛皮癬
  • 濕疹
  • 色素沉著過度
  • 其他

第 7 章全球局部皮質類固醇(類固醇)市場:按分銷渠道

  • 醫院藥房
  • 零售藥店
  • 網上藥店

第 8 章全球皮質類固醇(類固醇)市場:按地區劃分

  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章競爭態勢

  • 公司簡介
    • GlaxoSmithKline plc
    • Merck &Co., Inc.
    • Sandoz International GmbH
    • AstraZeneca
    • LEO Pharma
    • Cipla Inc.
    • Bristol-Myers Squibb Company
    • Almirall, SA
    • Bausch Health
    • Sanofi SA

第10章 章節

簡介目錄
Product Code: CMI5035

Topical steroids are available in a variety of strengths and are classified into seven classes based on their potency. Class I (class one) contains the strongest steroids, while Class VII contains the weakest (class seven).

Topical steroids in Class I are 600 to 1,000 times more powerful than those in Class VII. The right steroid strength, or potency, is determined by a number of factors.

Babies, for example, absorb topical steroids much faster than adults, so a low-potency steroid may be required.

Topical steroids are absorbed quickly in parts of the body where skin touches flesh, such as the armpits or beneath the breasts, or in sensitive areas of skin, such as the eyelids, and may only require a low-potency formulation.

Market Dynamics

Market players are focused on launching generic products, this is expected to contribute to growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in March 2019, Lupin Limited, an Indian pharmaceutical company announced the launch of Fluocinonide Ointment USP, 0.05 %, which was approved by the US Food and Drug Administration (FDA) in July 2018. Lupin's Fluocinonide Ointment USP, 0.05% is the generic equivalent of County Line Pharmaceuticals LLC's Lidex Ointment 0.05%. It is used to treat inflammatory and pruritic symptoms associated with corticosteroid-responsive dermatoses.

Market players are involved in strategies such as acquisitions, which is expected to contribute to growth of global topical corticosteroids (steroids) market. For instance, in October 2018, Mayne Pharma, a specialty pharmaceutical company, announced that it has acquired the US and Australia rights to halobetasol foam 0.05% for US$32.0 million. Halobetasol foam is a highly potent corticosteroid that is used to treat plaque psoriasis.

Increasing initiatives by non-profit organizations for better treatment of eczema is expected to aid growth of the global topical corticosteroids (steroids) market over the forecast period. For instance, in September 2021, on world eczema day (September 14), eleven patient organizations from eight countries came together to launch the Global Patient Initiative to Improve Eczema Care (GPIIEC). The programme is a global effort to develop a uniform "yardstick" for evaluating how well health systems respond to demands of patients and their caregivers. This groundbreaking collaboration has discovered aspects of health-care delivery that matter most to patients and caregivers, as well as indicators to assess them across eight developed countries (Australia, Canada, Denmark, France, Italy, Germany, United States, and the United Kingdom).

Key features of the study:

  • This report provides an in-depth analysis of global topical corticosteroids (steroids) market , provides market size (US$ Billion), and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global topical corticosteroids (steroids) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include GlaxoSmithKline plc, Merck & Co., Inc., Sandoz International GmbH, AstraZeneca, LEO Pharma, Cipla Inc., Bristol-Myers Squibb Company, Almirall, S.A., Bausch Health, and Sanofi SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global topical corticosteroids (steroids) market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global topical corticosteroids (steroids) market.

Detailed Segmentation:

  • Global Topical Corticosteroids (steroids) Market , By Formulation:
    • Creams
    • Ointments
    • Gels
    • Others (solutions, foams, spray, etc.)
  • Global Topical Corticosteroids (steroids) Market , By Application:
    • Acne
    • Dermatitis
    • Psoriasis
    • Eczema
    • Hyperpigmentation
    • Others (rash, etc.)
  • Global Topical Corticosteroids (steroids) Market , By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Topical Corticosteroids (steroids) Market , By Region:
    • North America
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • GlaxoSmithKline plc*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Developments/Updates
      • Strategies
    • Merck & Co., Inc.
    • Sandoz International GmbH
    • AstraZeneca
    • LEO Pharma
    • Cipla Inc.
    • Bristol-Myers Squibb Company
    • Almirall, S.A.
    • Bausch Health
    • Sanofi SA

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Formulation
    • Market Snippet, By Application
    • Market Snippet, By Distribution channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Porter's Analysis
  • Industry Trends
  • Key Highlights
  • Epidemiology
  • Reimbursement Scenario
  • Regulatory Scenario
  • Product Launch and Approvals
  • Acquisition and Collaboration Scenario

4. Global Topical Corticosteroids (steroids) Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Epidemiology
  • Impact of COVID-19 on Demand and Supply of Topical Corticosteroids
  • Impact of COVID-19 on the overall Healthcare Sector

5. Global Topical Corticosteroids (steroids) Market , By Formulation, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

6. Global Topical Corticosteroids (steroids) Market , By Application, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Acne
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Dermatitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Psoriasis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Eczema
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Hyperpigmentation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

7. Global Topical Corticosteroids (steroids) Market , By Distribution Channel, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Billion)

8. Global Topical Corticosteroids (steroids) Market , By Region, 2017-2030 (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2018-2030
    • Regional Trends
  • North America
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country, 2017-2030 (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Formulation, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Application, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Bn)
    • Market Size and Forecast, By Country/Region, 2017-2030 (US$ Bn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Merck & Co., Inc.
    • Sandoz International GmbH
    • AstraZeneca
    • LEO Pharma
    • Cipla Inc.
    • Bristol-Myers Squibb Company
    • Almirall, S.A.
    • Bausch Health
    • Sanofi SA

Key pointers provided are also applicable to other companies covered in the scope of the report.

10. Section

  • Research Methodology
  • About us
  • Contact